Heart failure with preserved ejection fraction in the elderly: scope of the problem
B Upadhya, GE Taffet, CP Cheng… - Journal of molecular and …, 2015 - Elsevier
Heart failure with preserved ejection fraction (HFpEF) is the most common form of heart
failure (HF) in older adults, particularly women, and is increasing in prevalence as the …
failure (HF) in older adults, particularly women, and is increasing in prevalence as the …
Heart failure with preserved ejection fraction in older adults
B Upadhya, DW Kitzman - Tresch and Aronow's Cardiovascular …, 2019 - taylorfrancis.com
Heart failure (HF) with preserved left ventricular (LV) ejection fraction (HFpEF) is uncommon
in younger persons, but highly prevalent in older adults, particularly women over age 80 …
in younger persons, but highly prevalent in older adults, particularly women over age 80 …
Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction
HA Shaltout, J Eggebeen, AP Marsh, PH Brubaker… - Nitric Oxide, 2017 - Elsevier
Aerobic exercise training is an effective therapy to improve peak aerobic power (peak VO 2)
in individuals with hypertension (HTN, AHA/ACC class A) and heart failure patients with …
in individuals with hypertension (HTN, AHA/ACC class A) and heart failure patients with …
Association is not causation: treatment effects cannot be estimated from observational data in heart failure
CJ Rush, RT Campbell, PS Jhund… - European heart …, 2018 - academic.oup.com
Aims Treatment 'effects' are often inferred from non-randomized and observational studies.
These studies have inherent biases and limitations, which may make therapeutic inferences …
These studies have inherent biases and limitations, which may make therapeutic inferences …
Heart failure with preserved ejection fraction in the elderly: basic mechanisms and clinical considerations
K Gharagozloo, M Mehdizadeh, G Heckman… - Canadian Journal of …, 2024 - Elsevier
Heart failure (HF) with preserved ejection fraction (HFpEF) refers to a clinical condition in
which the signs of HF, such as pulmonary congestion, peripheral edema and increased …
which the signs of HF, such as pulmonary congestion, peripheral edema and increased …
Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes
K Patel, GC Fonarow, OJ Ekundayo, IB Aban… - International journal of …, 2014 - Elsevier
Background We examined the clinical effectiveness of beta-blockers considered evidenced-
based to heart failure and reduced ejection fraction (HFrEF) and their recommended target …
based to heart failure and reduced ejection fraction (HFrEF) and their recommended target …
Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target
AS Manolis, AA Manolis, TA Manolis, H Melita - Heart failure reviews, 2019 - Springer
Heart failure (HF) with preserved ejection fraction (HFpEF) represents half of HF patients,
who are more likely older, women, and hypertensive. Mortality rates in HFpEF are higher …
who are more likely older, women, and hypertensive. Mortality rates in HFpEF are higher …
Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction
Background—Little is known about associations of calcium channel blockers (CCBs) with
outcomes in patients with heart failure and preserved ejection fraction (EF). Methods and …
outcomes in patients with heart failure and preserved ejection fraction (EF). Methods and …
Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions
B Upadhya, MJ Haykowsky, DW Kitzman - Heart failure reviews, 2018 - Springer
Heart failure (HF) with preserved ejection fraction (HFpEF) is the most common form of HF.
Among elderly women, HFpEF comprises more than 80% of incident HF cases. Adverse …
Among elderly women, HFpEF comprises more than 80% of incident HF cases. Adverse …
Beta-blocker use and 30-day all-cause readmission in Medicare beneficiaries with systolic heart failure
Background Beta-blockers improve outcomes in patients with systolic heart failure. However,
it is unknown whether their initial negative inotropic effect may increase 30-day all-cause …
it is unknown whether their initial negative inotropic effect may increase 30-day all-cause …